Skip to main content

Table 1 Patient characteristics

From: Growth characteristics of early-stage (IA) lung adenocarcinoma and its value in predicting lymph node metastasis

Variable

T1a (n = 52)

T1b (n = 65)

T1c (n = 27)

p-value

Gender

   

0.124

Female

35(67.3)

32(49.2)

17(63)

 

Male

17(32.7)

33(50.8)

10(37)

 

Age (years)

   

0.000

< 60

40(76.9)

26(40.0)

12(44.4)

 

≥ 60

12(23.1)

39(60.0)

15(55.6)

 

Family history of lung cancer

   

0.129

No

49(94.2)

54(83.1)

25(92.6)

 

Yes

3(5.8)

11(16.9)

2(7.4)

 

History of malignancy

   

0.254

No

46(88.5)

62(95.4)

23(85.2)

 

Yes

6(11.5)

3(4.6)

4(14.8)

 

Smoking index

   

0.710

Nonsmoker

36(69.2)

38(58.5)

18(66.7)

 

< 400

9(17.3)

10(15.4)

0(0)

 

≥ 400

7(13.5)

17(26.2)

9(33.3)

 

Surgery

   

0.827

Lobectomy

33(63.5)

43(66.2)

19(70.4)

 

Segmentectomy

19(36.5)

22(33.8)

8(29.6)

 

Location

   

0.191

Right upper lobe

15(28.8)

16(24.6)

7(25.9)

 

Right middle lobe

4(7.7)

3(4.6)

4(14.8)

 

Right lower lobe

10(19.2)

14(21.5)

2(7.4)

 

Left upper lobe

12(23.1)

23(35.4)

5(18.5)

 

Left lower lobe

11(21.2)

9(13.8)

9(33.3)

 

Nodule types

   

0.025

pSN

15(28.8)

7(10.8)

3(11.1)

 

SN

37(71.2)

58(89.2)

24(88.9)

 

Pathological types

   

0.000

AIS

3(5.8)

0(0)

0(0)

 

MIA

15(28.8)

4(6.2)

0(0)

 

IA

34(65.4)

61(93.8)

27(100)

 

LN Metastasis

   

0.000

No

50(96.2)

51(78.5)

16(59.3)

 

Yes

2(3.8)

14(21.5)

11(40.7)

 
  1. pSN: part-solid nodule; SN: solid nodule; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IA: invasive adenocarcinoma; LN: lymph node